ClearPoint Neuro (CLPT) Current Leases (2019 - 2026)
ClearPoint Neuro (CLPT) reported Current Leases of $234000.0 for Q1 2026, down 59.52% on a YoY basis from $578000.0 in Q1 2025, and down 66.28% sequentially from $694000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Current Leases (2019 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 8 years of Current Leases data on file, last reported at $234000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 59.52% year-over-year to $234000.0; the trailing twelve-month figure through Mar 2026 stood at $234000.0 (down 59.52% YoY), and the FY2025 full-year result was $694000.0, up 24.6% from the prior year.
- Current Leases declined to $234000.0 in Q1 2026, from $694000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $694000.0 in Q4 2025 to a low of $234000.0 in Q1 2026.
- A 5-year average of $489000.0 and a median of $521000.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 39.58% in 2024 and tumbled 59.52% in 2026, its largest moves.
- Tracing CLPT's Current Leases over 5 years: stood at $561000.0 in 2022, then fell by 24.42% to $424000.0 in 2023, then surged by 31.37% to $557000.0 in 2024, then rose by 24.6% to $694000.0 in 2025, then slumped by 66.28% to $234000.0 in 2026.
- Business Quant data shows CLPT's Current Leases at $234000.0 in Q1 2026, $694000.0 in Q4 2025, and $347000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 234,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Sep 30, 2025 | 347,000.00 |
| Jun 30, 2025 | 331,000.00 |
| Mar 31, 2025 | 578,000.00 |
| Dec 31, 2024 | 557,000.00 |
| Sep 30, 2024 | 536,000.00 |
| Jun 30, 2024 | 516,000.00 |
| Mar 31, 2024 | 497,000.00 |
| Dec 31, 2023 | 424,000.00 |
| Sep 30, 2023 | 384,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 571,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 537,000.00 |
| Jun 30, 2022 | 532,000.00 |
| Mar 31, 2022 | 521,000.00 |
| Dec 31, 2021 | 507,000.00 |
| Sep 30, 2021 | 486,000.00 |
| Jun 30, 2021 | 462,000.00 |